Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Efficacy, Safety, and Prognostic Factors of Dalpiciclib Combined with Endocrine Therapy After Progression on CDK4/6 Inhibitors in Patients with HR+/HER2- Advanced Breast Cancer: A Retrospective Study
Saved in:
| Published in: | Breast Cancer : Targets and Therapy |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1868552785590484993 |
|---|---|
| collection | WordPress RSS FRELIP Feed Integration |
| container_title | Breast Cancer : Targets and Therapy |
| description | |
| discipline_display | Oncology |
| discipline_facet | Oncology |
| format | Online Article RSS Article |
| genre | Journal Article |
| id | rss_article:61085 |
| institution | FRELIP |
| journal_source_facet | Breast Cancer : Targets and Therapy |
| last_indexed | 2026-06-20T21:26:07.255Z |
| publishDate | 2026 |
| publishDateSort | 2026 |
| record_format | rss_article |
| spellingShingle | Efficacy, Safety, and Prognostic Factors of Dalpiciclib Combined with Endocrine Therapy After Progression on CDK4/6 Inhibitors in Patients with HR+/HER2- Advanced Breast Cancer: A Retrospective Study Oncology General Oncology |
| sub_discipline_display | General |
| sub_discipline_facet | General |
| subject_display | Oncology General Oncology |
| subject_facet | Oncology General Oncology |
| title | Efficacy, Safety, and Prognostic Factors of Dalpiciclib Combined with Endocrine Therapy After Progression on CDK4/6 Inhibitors in Patients with HR+/HER2- Advanced Breast Cancer: A Retrospective Study |
| title_alt | Eficacia, seguridad y factores pronósticos de dalpiciclib combinado con terapia endocrina tras progresión a inhibidores de CDK4/6 en pacientes con cáncer de mama avanzado HR+/HER2-: un estudio retrospectivo Efficacité, sécurité et facteurs pronostiques du dalpiciclib combiné à l'hormonothérapie après progression sous inhibiteurs de CDK4/6 chez les patientes atteintes d'un cancer du sein avancé HR+/HER2- : une étude rétrospective Eficácia, segurança e fatores prognósticos de dalpiciclibe combinado com terapia endócrina após progressão em inibidores de CDK4/6 em pacientes com câncer de mama avançado HR+/HER2-: Um estudo retrospectivo |
| title_auth | Efficacy, Safety, and Prognostic Factors of Dalpiciclib Combined with Endocrine Therapy After Progression on CDK4/6 Inhibitors in Patients with HR+/HER2- Advanced Breast Cancer: A Retrospective Study |
| title_es_txt | Eficacia, seguridad y factores pronósticos de dalpiciclib combinado con terapia endocrina tras progresión a inhibidores de CDK4/6 en pacientes con cáncer de mama avanzado HR+/HER2-: un estudio retrospectivo |
| title_fr_txt | Efficacité, sécurité et facteurs pronostiques du dalpiciclib combiné à l'hormonothérapie après progression sous inhibiteurs de CDK4/6 chez les patientes atteintes d'un cancer du sein avancé HR+/HER2- : une étude rétrospective |
| title_full | Efficacy, Safety, and Prognostic Factors of Dalpiciclib Combined with Endocrine Therapy After Progression on CDK4/6 Inhibitors in Patients with HR+/HER2- Advanced Breast Cancer: A Retrospective Study |
| title_fullStr | Efficacy, Safety, and Prognostic Factors of Dalpiciclib Combined with Endocrine Therapy After Progression on CDK4/6 Inhibitors in Patients with HR+/HER2- Advanced Breast Cancer: A Retrospective Study |
| title_full_unstemmed | Efficacy, Safety, and Prognostic Factors of Dalpiciclib Combined with Endocrine Therapy After Progression on CDK4/6 Inhibitors in Patients with HR+/HER2- Advanced Breast Cancer: A Retrospective Study |
| title_pt_txt | Eficácia, segurança e fatores prognósticos de dalpiciclibe combinado com terapia endócrina após progressão em inibidores de CDK4/6 em pacientes com câncer de mama avançado HR+/HER2-: Um estudo retrospectivo |
| title_short | Efficacy, Safety, and Prognostic Factors of Dalpiciclib Combined with Endocrine Therapy After Progression on CDK4/6 Inhibitors in Patients with HR+/HER2- Advanced Breast Cancer: A Retrospective Study |
| title_sort | efficacy, safety, and prognostic factors of dalpiciclib combined with endocrine therapy after progression on cdk4/6 inhibitors in patients with hr+/her2- advanced breast cancer: a retrospective study |
| topic | Oncology General Oncology |
| url | https://www.dovepress.com/efficacy-safety-and-prognostic-factors-of-dalpiciclib-combined-with-en-peer-reviewed-fulltext-article-BCTT |